Kerala Ayurveda Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kerala Ayurveda Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $21.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kerala Ayurveda Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $21.7K Trade | TransData Nexus

Kerala Ayurveda Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $21.7K Total Trade · DGFT Verified

Kerala Ayurveda Limited is an Indian pharmaceutical exporter with a total trade value of $21.7K across 2 products in 1 therapeutic categories. Based on 40 verified export shipments from Indian Customs (DGFT) records, Kerala Ayurveda Limited is the #1 Indian exporter in 1 product including Adaptogen. Top exports include Asava ($15.5K), Adaptogen ($6.2K), .

Kerala Ayurveda Limited — Export Portfolio & Destination Treemap

Kerala Ayurveda Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Kerala Ayurveda Limited? — Company Overview & Market Position

Kerala Ayurveda Limited, established in 1945 by Ayurveda Acharya Vaidyan KGK Panicker, is a pioneer in authentic Ayurvedic healing with over 80 years of heritage. Headquartered in Aluva, Ernakulam District, Kerala, India, the company operates as a public limited entity with the Corporate Identification Number (CIN) L24233KL1992PLC006592. As of March 12, 2026, Kerala Ayurveda Limited's stock was listed on the Bombay Stock Exchange under the ticker symbol 530163, with a closing price of ₹188.25. The company employs approximately 501-1,000 individuals, reflecting its substantial presence in the Ayurvedic healthcare sector. For more information, visit their official website at keralaayurveda.biz.

What Does Kerala Ayurveda Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Asava$15.5K 2Adaptogen$6.2K

Kerala Ayurveda Limited Therapeutic Categories — 1 Specializations

Product Portfolio — Top 2 by Export Value

Kerala Ayurveda Limited exports 2 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Asava	Ayurvedic & Herbal Products	$15.5K	28	3.4%	5
2	Adaptogen	Ayurvedic & Herbal Products	$6.2K	12	100.0%	1

Kerala Ayurveda Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $21.7K. The company is the #1 Indian exporter in 1 product: Adaptogen. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Kerala Ayurveda Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Kerala Ayurveda Limited's primary manufacturing facility is located in Athani, near Aluva, Ernakulam District, Kerala. This plant specializes in the production of Ayurvedic medicines, including tablets, capsules, syrups, and other dosage forms. The facility adheres to Good Manufacturing Practice (GMP) standards, ensuring the safety, purity, and efficacy of its products. (keralaayurveda.biz) The company has also expanded its operations internationally, with a wellness center and treatment facility in Fremont, California, USA, established to promote Ayurveda in the United States.

3Key Leadership

The leadership team at Kerala Ayurveda Limited comprises several key executives:

Ramesh Vangal: Non-Executive Chairman
Kunjupanicker Anilkumar: Whole Time Director
Anand Subramanian: Director
Subramaniam Krishnamurthy: Director
Harish Kuttan Menon: Director
Gokul Patnaik: Director
Shilpa Kiran Gududur: Director
Thomas Karapparambil George: Director
Rajesh Sharma: Director
Jyothikumari: Director

These individuals collectively guide the strategic direction and operations of Kerala Ayurveda Limited, leveraging their diverse expertise to uphold the company's commitment to authentic Ayurvedic healing.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kerala Ayurveda Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kerala Ayurveda Limited has made strategic efforts to expand its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. In the U.S., the company has established a wellness center and treatment facility in Fremont, California, to promote Ayurveda and cater to the growing interest in alternative medicine. While specific regulatory filings and approvals in the EU, UK, Australia, and Japan are not publicly detailed, the company's international expansion indicates a proactive approach to meeting the regulatory requirements of these markets. The focus on wellness centers and treatment facilities suggests an emphasis on providing Ayurvedic services in addition to product exports.

2Emerging Markets

Kerala Ayurveda Limited has demonstrated a commitment to emerging markets by establishing a subsidiary in Singapore named Nutraveda Pte. Ltd. in June 2009. This subsidiary was incorporated to market natural and herbal value-added products globally, thereby delivering wellness and nutritional benefits to international markets. Additionally, the company's expansion into the U.S. market through the Fremont wellness center reflects a strategic move to tap into the growing interest in Ayurvedic treatments and products in North America. While specific activities in Africa, Latin America, and Southeast Asia are not detailed, the establishment of international subsidiaries and facilities indicates a strategic focus on global market penetration.

Kerala Ayurveda Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Kerala Ayurveda Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's international expansion, including the establishment of a wellness center in Fremont, California, suggests an awareness of the regulatory requirements in the U.S. market. However, without publicly accessible records, a comprehensive assessment of the company's FDA compliance status cannot be made.

2WHO & EU GMP

Information regarding Kerala Ayurveda Limited's World Health Organization (WHO) prequalification, European Union Good Manufacturing Practice (EU GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. The company's adherence to Good Manufacturing Practice (GMP) standards at its manufacturing facility in Athani, Kerala, indicates a commitment to quality. (keralaayurveda.biz) However, without specific certifications or prequalification statuses, it is challenging to assess the company's compliance with international standards.

3CDSCO & Indian Regulatory

Kerala Ayurveda Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Kerala Ayurveda Limited operates in the Ayurvedic and herbal products sector, facing competition from both domestic and international companies. Domestically, competitors include companies like Himalaya Drug Company and Dabur India Limited, which have established brands and extensive distribution networks. Internationally, the company competes with global herbal product manufacturers such as Himalaya Wellness Company and Patanjali Ayurved Limited. While Kerala Ayurveda Limited holds a 100% market share in the Adaptogen category, its overall market share across all products is relatively small, indicating a niche position in the market. The company's focus on authentic Ayurvedic formulations and holistic wellness services differentiates it from competitors.

2Key Differentiators

Kerala Ayurveda Limited's key differentiators include its over 80 years of heritage in authentic Ayurvedic healing, a comprehensive product portfolio encompassing over 350 classical and proprietary formulations, and a holistic approach that integrates wellness resorts, hospitals, clinics, academies, and manufacturing facilities. The company's commitment to Good Manufacturing Practice (GMP) standards and its international expansion efforts further enhance its competitive edge. These factors collectively position Kerala Ayurveda Limited as a unique player in the Ayurvedic healthcare sector.

Strategic Position

Buyer Due Diligence Brief — Evaluating Kerala Ayurveda Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Kerala Ayurveda Limited has a track record of consistent export activity, with a total export value of $22,000 USD across 40 shipments from 2022 to 2026. The company's portfolio is highly concentrated, with the top five products accounting for 100% of its exports. Notably, it holds a 100% market share in the Adaptogen category, indicating a strong position in this segment. The company's adherence to GMP standards and its international expansion efforts suggest reliability and a commitment to quality.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration (FDA) to ensure compliance with U.S. regulations.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Kerala Ayurveda Limited

How many pharmaceutical products does Kerala Ayurveda Limited export from India?

Kerala Ayurveda Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Asava ($15.5K), Adaptogen ($6.2K). Total export value is $21.7K.

What is Kerala Ayurveda Limited's total pharmaceutical export value?

Kerala Ayurveda Limited's total pharmaceutical export value is $21.7K, based on 40 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Kerala Ayurveda Limited the #1 Indian exporter?

Kerala Ayurveda Limited is the #1 Indian exporter in 1 products: Adaptogen (100.0% market share).

What therapeutic categories does Kerala Ayurveda Limited cover?

Kerala Ayurveda Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Kerala Ayurveda Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.